YBX1 and breast cancer: Fluorescence imaging revealed that overexpression of CD2BP2‐DT significantly enhanced the formation of YBX1 droplets, while knockdown of CD2BP2‐DT markedly inhibited YBX1 droplet formation in breast cancer cells (Figure6A; Figure S5A, Supporting Information).